PLRZ
Price:
$14.5
Market Cap:
$14.21M
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.
Industry
Biotechnology
IPO Date
2024-10-29
Stock Exchange
NASDAQ
Ticker
PLRZ
According to Polyrizon Ltd.’s latest financial reports and current stock price. The company's current ROE is -8.09%. This represents a change of 78.75% compared to the average of -4.53% of the last 4 quarters.
The mean historical ROE of Polyrizon Ltd. over the last ten years is 4.46%. The current -8.09% ROE has changed -100.18% with respect to the historical average. Over the past ten years (40 quarters), PLRZ's ROE was at its highest in in the December 2021 quarter at 18.60%. The ROE was at its lowest in in the December 2023 quarter at -717.54%.
Average
4.46%
Median
-29.23%
Minimum
-1052.63%
Maximum
23.70%
Discovering the peaks and valleys of Polyrizon Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 23.70%
Minimum Annual Increase = -5294.52%
Minimum Annual ROE = -1052.63%
| Year | ROE | Change |
|---|---|---|
| 2024 | -29.23% | -97.22% |
| 2023 | -1052.63% | -981.02% |
| 2022 | 119.48% | -99.50% |
| 2021 | 23.70% | -5294.52% |
The current ROE of Polyrizon Ltd. (PLRZ) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-320.79%
5-year avg
4.46%
10-year avg
4.46%
Polyrizon Ltd.’s ROE is greater than Cyclerion Therapeutics, Inc. (-24.61%), greater than XTL Biopharmaceuticals Ltd. (-33.89%), greater than Alaunos Therapeutics, Inc. (-167.97%), greater than Pasithea Therapeutics Corp. (-99.53%), greater than Quoin Pharmaceuticals, Ltd. (-210.51%), greater than VYNE Therapeutics Inc. (-80.55%), less than Radiopharm Theranostics Limited (0%), greater than PharmaCyte Biotech, Inc. (-2.51%), less than NovaBay Pharmaceuticals, Inc. (117.09%), less than AIM ImmunoTech Inc. (353.89%),
| Company | ROE | Market cap |
|---|---|---|
| -24.61% | $5.67M | |
| -33.89% | $4.76M | |
| -167.97% | $8.01M | |
| -99.53% | $8.63M | |
| -210.51% | $11.12M | |
| -80.55% | $6.24M | |
| 0% | $5.91M | |
| -2.51% | $8.22M | |
| 117.09% | $6.55M | |
| 353.89% | $4.19M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Polyrizon Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Polyrizon Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Polyrizon Ltd.'s ROE?
How is the ROE calculated for Polyrizon Ltd. (PLRZ)?
What is the highest ROE for Polyrizon Ltd. (PLRZ)?
What is the 3-year average ROE for Polyrizon Ltd. (PLRZ)?
What is the 5-year average ROE for Polyrizon Ltd. (PLRZ)?
How does the current ROE for Polyrizon Ltd. (PLRZ) compare to its historical average?